Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
2.967
-0.083 (-2.71%)
Nov 21, 2024, 11:56 AM EST - Market open
Vigil Neuroscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 28.01 | 27.93 | 21.44 | 10.08 | 3.55 |
| Research & Development | 60.42 | 60.93 | 47.44 | 32.33 | 9.03 |
| Operating Expenses | 88.43 | 88.87 | 68.88 | 42.41 | 12.58 |
| Operating Income | -88.43 | -88.87 | -68.88 | -42.41 | -12.58 |
| Interest & Investment Income | 5.82 | 6.24 | 0.62 | 0 | - |
| Other Non Operating Income (Expenses) | 0.01 | -0.01 | -0.04 | -0.88 | -2.66 |
| EBT Excluding Unusual Items | -82.6 | -82.64 | -68.31 | -43.28 | -15.25 |
| Pretax Income | -82.6 | -82.64 | -68.31 | -43.28 | -57.09 |
| Net Income | -82.6 | -82.64 | -68.31 | -43.28 | -57.09 |
| Net Income to Common | -82.6 | -82.64 | -68.31 | -43.28 | -57.09 |
| Shares Outstanding (Basic) | 40 | 39 | 32 | 2 | 1 |
| Shares Outstanding (Diluted) | 40 | 39 | 32 | 2 | 1 |
| Shares Change (YoY) | 3.41% | 22.18% | 1968.64% | 13.48% | - |
| EPS (Basic) | -2.07 | -2.13 | -2.16 | -28.26 | -42.30 |
| EPS (Diluted) | -2.07 | -2.13 | -2.16 | -28.26 | -42.30 |
| Free Cash Flow | -48.61 | -71.04 | -66.07 | -39.55 | -10.36 |
| Free Cash Flow Per Share | -1.22 | -1.84 | -2.09 | -25.82 | -7.68 |
| EBITDA | -87.97 | -88.47 | -68.81 | -42.38 | - |
| D&A For EBITDA | 0.45 | 0.4 | 0.08 | 0.03 | - |
| EBIT | -88.43 | -88.87 | -68.88 | -42.41 | -12.58 |
Source: S&P Capital IQ. Standard template.
Financial Sources.